BSCRX | SSGSX | BSCRX / SSGSX | |
Total Expense Ratio | 0.73 | 1.26 | 58% |
Annual Report Gross Expense Ratio | 1.28 | 1.26 | 102% |
Fund Existence | 7 years | 26 years | - |
Gain YTD | 0.503 | -7.215 | -7% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 129M | 5.67B | 2% |
Annual Yield % from dividends | 0.51 | 0.54 | 94% |
Returns for 1 year | 9.55 | -10.83 | -88% |
Returns for 3 years | 50.04 | -5.32 | -941% |
Returns for 5 years | 130.96 | 26.99 | 485% |
Returns for 10 years | N/A | 9.83 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BKEM | 63.56 | -0.01 | -0.02% |
BNY Mellon Emerging Markets Equity ETF | |||
FTXH | 25.18 | -0.52 | -2.02% |
First Trust Nasdaq Pharmaceuticals ETF | |||
DFNL | 40.34 | -0.84 | -2.04% |
Davis Select Financial ETF | |||
VIOG | 109.76 | -2.41 | -2.15% |
Vanguard S&P Small-Cap 600 Growth ETF | |||
IJJ | 118.98 | -3.49 | -2.85% |
iShares S&P Mid-Cap 400 Value ETF |